Aviva PLC Decreases Position in Waters Co. (WAT)

Aviva PLC cut its stake in shares of Waters Co. (NYSE:WAT) by 3.9% during the 3rd quarter, Holdings Channel reports. The firm owned 37,440 shares of the medical instruments supplier’s stock after selling 1,525 shares during the period. Aviva PLC’s holdings in Waters were worth $7,289,000 at the end of the most recent reporting period.

Several other institutional investors also recently made changes to their positions in the stock. Fort L.P. bought a new stake in Waters during the 2nd quarter worth approximately $118,000. Checchi Capital Advisers LLC bought a new stake in Waters during the 3rd quarter worth approximately $201,000. First Hawaiian Bank bought a new stake in Waters during the 3rd quarter worth approximately $208,000. Mission Wealth Management LP bought a new stake in Waters during the 3rd quarter worth approximately $208,000. Finally, CLARET ASSET MANAGEMENT Corp bought a new stake in Waters during the 3rd quarter worth approximately $209,000. 98.51% of the stock is currently owned by institutional investors.

A number of research firms have weighed in on WAT. Goldman Sachs Group lowered shares of Waters from a “neutral” rating to a “sell” rating and reduced their target price for the stock from $185.00 to $180.00 in a report on Friday, November 30th. ValuEngine raised shares of Waters from a “hold” rating to a “buy” rating in a report on Tuesday, November 27th. Zacks Investment Research lowered shares of Waters from a “hold” rating to a “sell” rating in a report on Monday, September 24th. Leerink Swann lowered shares of Waters from an “outperform” rating to a “market perform” rating in a report on Monday, October 8th. Finally, UBS Group began coverage on shares of Waters in a report on Tuesday, October 9th. They set a “neutral” rating and a $210.00 target price on the stock. Three research analysts have rated the stock with a sell rating, eleven have issued a hold rating and four have assigned a buy rating to the company. The company currently has a consensus rating of “Hold” and an average target price of $205.07.

In other news, Director Christopher A. Kuebler sold 8,000 shares of the business’s stock in a transaction that occurred on Friday, November 16th. The shares were sold at an average price of $199.67, for a total value of $1,597,360.00. Following the transaction, the director now owns 18,911 shares in the company, valued at approximately $3,775,959.37. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Thomas P. Salice sold 3,500 shares of the business’s stock in a transaction that occurred on Wednesday, October 31st. The stock was sold at an average price of $192.00, for a total transaction of $672,000.00. Following the completion of the transaction, the director now owns 20,911 shares in the company, valued at approximately $4,014,912. The disclosure for this sale can be found here. 0.98% of the stock is currently owned by insiders.

Shares of NYSE WAT opened at $195.45 on Thursday. The company has a market capitalization of $15.04 billion, a PE ratio of 26.09, a PEG ratio of 2.41 and a beta of 0.97. Waters Co. has a 52-week low of $167.93 and a 52-week high of $220.20. The company has a debt-to-equity ratio of 0.61, a quick ratio of 5.93 and a current ratio of 6.63.

Waters (NYSE:WAT) last issued its quarterly earnings results on Tuesday, October 23rd. The medical instruments supplier reported $1.92 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.90 by $0.02. The firm had revenue of $578.02 million for the quarter, compared to the consensus estimate of $587.43 million. Waters had a net margin of 2.32% and a return on equity of 30.68%. The company’s revenue for the quarter was up 2.2% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.77 EPS. On average, equities research analysts expect that Waters Co. will post 8.05 EPS for the current year.

ILLEGAL ACTIVITY NOTICE: This piece of content was originally posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this piece of content on another domain, it was illegally copied and republished in violation of US and international trademark and copyright legislation. The correct version of this piece of content can be read at https://www.dispatchtribunal.com/2018/12/06/aviva-plc-decreases-position-in-waters-co-wat.html.

Waters Company Profile

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in the United States, Europe, Asia, and internationally. It designs, manufactures, sells, and services high and ultra performance liquid chromatography technology, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Further Reading: Why does a company issue an IPO?

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WAT).

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply